Sterling Johnson, PhD, Jean R. Finley Professor of Geriatrics and Dementia, Geriatrics and Gerontology, will lead a five-year study that aims to provide state-of-the-art imaging and blood-based biomarkers for researchers around the world to study and advance the field of Alzheimer’s and related dementias.

The study, called Clarity in Alzheimer’s Disease and Related Dementias Research Through Imaging (CLARiTI), will gather data showing the presence, absence or change in characteristic disease biomarkers in people who have dementia or are at risk of developing it. The study will involve all of the 37 Alzheimer's Disease Research Centers in the United States.

“This study represents a significant milestone in Alzheimer's research,” says Dr. Johnson. “By collaborating across our Alzheimer’s Disease Research Centers network, we can shed light on the complex interplay of multiple pathologies contributing to dementia, ultimately advancing our understanding and treatment of this devastating condition.”

The work is supported by a $150 million grant from the National Institutes of Health (NIH)—the largest NIH grant ever awarded to the University of Wisconsin–Madison.

Read the full story from the UW School of Medicine and Public Health.

Banner: Sterling Johnson, PhD, will lead the CLARiTI study. Credit: Clint Thayer/Department of Medicine.